Id |
Subject |
Object |
Predicate |
Lexical cue |
T100 |
0-7 |
Sentence |
denotes |
RESULTS |
T6214 |
9-89 |
Sentence |
denotes |
Absence of IRF-4 expression in leukemia cells is not due to promoter alterations |
T101 |
9-89 |
Sentence |
denotes |
Absence of IRF-4 expression in leukemia cells is not due to promoter alterations |
T6215 |
90-206 |
Sentence |
denotes |
We have previously demonstrated a lack of IRF-4 expression in leukemia patients and specifically in CML T-cells (3). |
T102 |
90-206 |
Sentence |
denotes |
We have previously demonstrated a lack of IRF-4 expression in leukemia patients and specifically in CML T-cells (3). |
T6216 |
207-666 |
Sentence |
denotes |
Here, we demonstrate the absence of IRF-4 expression in various hematopoietic cell lines, such as Jurkat, a T-cell leukemia, CML-T1, a bcr-abl-positive T-cell line, K-562, a bcr-abl-positve erythroleukemia, U-937, a monocytic leukemia, EM-2 and LAMA-84, bcr-abl-positve myeloid leukemia, but not in SD-1, a bcr-abl-positive acute lymphoblastic leukemia (pre B-ALL), RPMI-8226, a multiple myeloma and BV-173, a bcr-abl-positive B-cell line (Figures 1A and 5D). |
T103 |
207-666 |
Sentence |
denotes |
Here, we demonstrate the absence of IRF-4 expression in various hematopoietic cell lines, such as Jurkat, a T-cell leukemia, CML-T1, a bcr-abl-positive T-cell line, K-562, a bcr-abl-positve erythroleukemia, U-937, a monocytic leukemia, EM-2 and LAMA-84, bcr-abl-positve myeloid leukemia, but not in SD-1, a bcr-abl-positive acute lymphoblastic leukemia (pre B-ALL), RPMI-8226, a multiple myeloma and BV-173, a bcr-abl-positive B-cell line (Figures 1A and 5D). |
T6217 |
667-823 |
Sentence |
denotes |
After sequencing of the IRF-4 promoter, it could be excluded that absence of IRF-4 expression in any of the above cell lines was due to genetic aberrations. |
T104 |
667-823 |
Sentence |
denotes |
After sequencing of the IRF-4 promoter, it could be excluded that absence of IRF-4 expression in any of the above cell lines was due to genetic aberrations. |
T6218 |
824-996 |
Sentence |
denotes |
However, 2 bp changes (nucleotide −1081, T→C and −1068, A→C) could be detected in both the IRF-4-positive BV-173 and the IRF-4-negative LAMA-84, EM-2 and K-562 (Figure 1B). |
T105 |
824-996 |
Sentence |
denotes |
However, 2 bp changes (nucleotide −1081, T→C and −1068, A→C) could be detected in both the IRF-4-positive BV-173 and the IRF-4-negative LAMA-84, EM-2 and K-562 (Figure 1B). |
T6219 |
997-1202 |
Sentence |
denotes |
At position −116 an A→C substitution was found in EM-2, K-562 and CML-T1, whereas Jurkat, BV-173 and SD-1 exhibited a mixed A/C sequence and U-937, LAMA-84 and RPMI-8226 no substitution at all (Figure 1B). |
T106 |
997-1202 |
Sentence |
denotes |
At position −116 an A→C substitution was found in EM-2, K-562 and CML-T1, whereas Jurkat, BV-173 and SD-1 exhibited a mixed A/C sequence and U-937, LAMA-84 and RPMI-8226 no substitution at all (Figure 1B). |
T6220 |
1203-1275 |
Sentence |
denotes |
Consequently, these alterations are unlikely to affect IRF-4 expression. |
T107 |
1203-1275 |
Sentence |
denotes |
Consequently, these alterations are unlikely to affect IRF-4 expression. |
T7004 |
1277-1358 |
Sentence |
denotes |
Increase of IRF-4 expression in hematopoietic cells after demethylating treatment |
T108 |
1277-1358 |
Sentence |
denotes |
Increase of IRF-4 expression in hematopoietic cells after demethylating treatment |
T7005 |
1359-1466 |
Sentence |
denotes |
We next analyzed whether promoter methylation could be responsible for down-regulation of IRF-4 expression. |
T109 |
1359-1466 |
Sentence |
denotes |
We next analyzed whether promoter methylation could be responsible for down-regulation of IRF-4 expression. |
T7006 |
1467-1573 |
Sentence |
denotes |
A region including exon1 in the IRF-4 promoter exhibited a large number of CpG-rich sequences (Figure 3A). |
T110 |
1467-1573 |
Sentence |
denotes |
A region including exon1 in the IRF-4 promoter exhibited a large number of CpG-rich sequences (Figure 3A). |
T7007 |
1574-1770 |
Sentence |
denotes |
Several chemical substances such as 5-aza-2-deoxycytidine (AzadC) or 5-azacytidine (AzaC) inhibit de novo and maintenance methylation, and thus can be used to discern promoter methylation (32,33). |
T111 |
1574-1770 |
Sentence |
denotes |
Several chemical substances such as 5-aza-2-deoxycytidine (AzadC) or 5-azacytidine (AzaC) inhibit de novo and maintenance methylation, and thus can be used to discern promoter methylation (32,33). |
T7008 |
1771-1814 |
Sentence |
denotes |
We used AzadC to generate unmethylated DNA. |
T112 |
1771-1814 |
Sentence |
denotes |
We used AzadC to generate unmethylated DNA. |
T7009 |
1815-1998 |
Sentence |
denotes |
A 72 h AzadC-treatment resulted in a concentration-dependent activation of IRF-4 transcription in Jurkat and CML-T1 T-cells as well as in U-937, K-562 and EM-2 cell lines (Figure 2A). |
T113 |
1815-1998 |
Sentence |
denotes |
A 72 h AzadC-treatment resulted in a concentration-dependent activation of IRF-4 transcription in Jurkat and CML-T1 T-cells as well as in U-937, K-562 and EM-2 cell lines (Figure 2A). |
T7010 |
1999-2166 |
Sentence |
denotes |
IRF-4 transcription was induced in a time-dependent manner and was observed as early as 24 h after treatment with AzadC and increased over time until 72 h (Figure 2B). |
T114 |
1999-2166 |
Sentence |
denotes |
IRF-4 transcription was induced in a time-dependent manner and was observed as early as 24 h after treatment with AzadC and increased over time until 72 h (Figure 2B). |
T7011 |
2167-2317 |
Sentence |
denotes |
Time and strength of the appearance of IRF-4 transcripts varied among cell lines, i.e. CML-T1 responded strongest to AzadC-treatment (data not shown). |
T115 |
2167-2317 |
Sentence |
denotes |
Time and strength of the appearance of IRF-4 transcripts varied among cell lines, i.e. CML-T1 responded strongest to AzadC-treatment (data not shown). |
T7012 |
2318-2453 |
Sentence |
denotes |
In line with this, AzadC-treatment of CML-T1 and LAMA-84 cells also translated in an induction of IRF-4 protein expression (Figure 2C). |
T116 |
2318-2453 |
Sentence |
denotes |
In line with this, AzadC-treatment of CML-T1 and LAMA-84 cells also translated in an induction of IRF-4 protein expression (Figure 2C). |
T7013 |
2454-2593 |
Sentence |
denotes |
Accordingly, treatment of the IRF-4-positive cell line BV-173, SD-1 and RPMI-8226 with AzadC had no effect on IRF-4 expression (Figure 2D). |
T117 |
2454-2593 |
Sentence |
denotes |
Accordingly, treatment of the IRF-4-positive cell line BV-173, SD-1 and RPMI-8226 with AzadC had no effect on IRF-4 expression (Figure 2D). |
T7014 |
2594-2735 |
Sentence |
denotes |
There was no difference in the effects of AzaC versus AzadC, as both increased the IRF-4 mRNA level in CML-T1 cells as well (data not shown). |
T118 |
2594-2735 |
Sentence |
denotes |
There was no difference in the effects of AzaC versus AzadC, as both increased the IRF-4 mRNA level in CML-T1 cells as well (data not shown). |
T7015 |
2736-2921 |
Sentence |
denotes |
This implied that promoter methylation may control IRF-4 expression, but an alternative explanation may be activation of positive transcriptional regulators of IRF-4 by AzadC (or AzaC). |
T119 |
2736-2921 |
Sentence |
denotes |
This implied that promoter methylation may control IRF-4 expression, but an alternative explanation may be activation of positive transcriptional regulators of IRF-4 by AzadC (or AzaC). |
T7831 |
2923-3023 |
Sentence |
denotes |
Methylation-sensitive enzymes do not cut specific sites in the IRF-4 promoter in hematopoietic cells |
T120 |
2923-3023 |
Sentence |
denotes |
Methylation-sensitive enzymes do not cut specific sites in the IRF-4 promoter in hematopoietic cells |
T7832 |
3024-3263 |
Sentence |
denotes |
To further investigate promoter methylation as a regulatory mechanism of IRF-4 gene expression, restriction-PCR-assays were performed (20,24), where only methylated DNA would not be cut enabling subsequent PCR amplification and vice versa. |
T121 |
3024-3263 |
Sentence |
denotes |
To further investigate promoter methylation as a regulatory mechanism of IRF-4 gene expression, restriction-PCR-assays were performed (20,24), where only methylated DNA would not be cut enabling subsequent PCR amplification and vice versa. |
T7833 |
3264-3441 |
Sentence |
denotes |
Genomic DNA from leukemic cells Jurkat, CML-T1, U-937, K-562, EM-2 and BV-173 was digested with the methylation-sensitive enzymes HpaII, Bsh1236I and HaeII-isochizomer Bsp143II. |
T122 |
3264-3441 |
Sentence |
denotes |
Genomic DNA from leukemic cells Jurkat, CML-T1, U-937, K-562, EM-2 and BV-173 was digested with the methylation-sensitive enzymes HpaII, Bsh1236I and HaeII-isochizomer Bsp143II. |
T7834 |
3442-3567 |
Sentence |
denotes |
EcoRI, which has no recognition site within the IRF-4 promoter, and the methylation-resistant enzyme MspI served as controls. |
T123 |
3442-3567 |
Sentence |
denotes |
EcoRI, which has no recognition site within the IRF-4 promoter, and the methylation-resistant enzyme MspI served as controls. |
T7835 |
3568-3669 |
Sentence |
denotes |
Two separate amplification reactions were performed, generating two fragments, F1 and F2 (Figure 3A). |
T124 |
3568-3669 |
Sentence |
denotes |
Two separate amplification reactions were performed, generating two fragments, F1 and F2 (Figure 3A). |
T7836 |
3670-3956 |
Sentence |
denotes |
After digestion with HpaII and Bsp143II a sufficient PCR amplification of F1 and F2 was detected in DNA from IRF-4-negative Jurkat, CML-T1, U-937, K-562 and EM-2 cells, suggesting a promoter methylation (and restriction protection) at the respective recognition sites (Figure 3B and C). |
T125 |
3670-3956 |
Sentence |
denotes |
After digestion with HpaII and Bsp143II a sufficient PCR amplification of F1 and F2 was detected in DNA from IRF-4-negative Jurkat, CML-T1, U-937, K-562 and EM-2 cells, suggesting a promoter methylation (and restriction protection) at the respective recognition sites (Figure 3B and C). |
T7837 |
3957-4092 |
Sentence |
denotes |
Notably, in IRF-4-positive SD-1 cells digestion with the methylation-sensitive enzymes completely inhibited amplification of F1 and F2. |
T126 |
3957-4092 |
Sentence |
denotes |
Notably, in IRF-4-positive SD-1 cells digestion with the methylation-sensitive enzymes completely inhibited amplification of F1 and F2. |
T7838 |
4093-4289 |
Sentence |
denotes |
In IRF-4-positive BV-173 cells a HpaII, but not a Bsh1236I digestion, significantly reduced the amplifiable DNA message of F2 (Figure 3C), whereas amplification of F1 was not affected (Figure 3B). |
T127 |
4093-4289 |
Sentence |
denotes |
In IRF-4-positive BV-173 cells a HpaII, but not a Bsh1236I digestion, significantly reduced the amplifiable DNA message of F2 (Figure 3C), whereas amplification of F1 was not affected (Figure 3B). |
T7839 |
4290-4485 |
Sentence |
denotes |
This implied that IRF-4 transcription in SD-1 and BV-173 cells is associated with less promoter methylation (in BV-173 especially at HpaII sites) as compared with the tested IRF-4-negative cells. |
T128 |
4290-4485 |
Sentence |
denotes |
This implied that IRF-4 transcription in SD-1 and BV-173 cells is associated with less promoter methylation (in BV-173 especially at HpaII sites) as compared with the tested IRF-4-negative cells. |
T8559 |
4487-4565 |
Sentence |
denotes |
Specific CpG sites in the IRF-4 promoter are methylated in hematopoietic cells |
T129 |
4487-4565 |
Sentence |
denotes |
Specific CpG sites in the IRF-4 promoter are methylated in hematopoietic cells |
T8560 |
4566-4897 |
Sentence |
denotes |
In order to exactly map the methylation sites within the IRF-4 promoter, we treated DNA of Jurkat, CML-T1, U-937, K-562 and EM-2 cells as well as of SD-1, RPMI-8226 and BV-173 control cells with bisulfite, which chemically converts unmethylated cytosine to uracil, whereas it has no effect on methylated cytosine, i.e. in CpG (34). |
T130 |
4566-4897 |
Sentence |
denotes |
In order to exactly map the methylation sites within the IRF-4 promoter, we treated DNA of Jurkat, CML-T1, U-937, K-562 and EM-2 cells as well as of SD-1, RPMI-8226 and BV-173 control cells with bisulfite, which chemically converts unmethylated cytosine to uracil, whereas it has no effect on methylated cytosine, i.e. in CpG (34). |
T8561 |
4898-4980 |
Sentence |
denotes |
This technique is especially useful for detection of unknown methylation patterns. |
T131 |
4898-4980 |
Sentence |
denotes |
This technique is especially useful for detection of unknown methylation patterns. |
T8562 |
4981-5160 |
Sentence |
denotes |
PCR amplification, cloning and sequencing of the bisulfite-treated DNA showed a specific methylation pattern of the analyzed 62 CpG sites in all cell lines (Figure 4 and Table 1). |
T132 |
4981-5160 |
Sentence |
denotes |
PCR amplification, cloning and sequencing of the bisulfite-treated DNA showed a specific methylation pattern of the analyzed 62 CpG sites in all cell lines (Figure 4 and Table 1). |
T8563 |
5161-5360 |
Sentence |
denotes |
In general, the methylational status ranged from one cell line with a nearly non-methylated IRF-4 promoter (SD-1, IRF-4-positive) to a completely methylated IRF-4 promoter in CML-T1 (IRF-4-negative). |
T133 |
5161-5360 |
Sentence |
denotes |
In general, the methylational status ranged from one cell line with a nearly non-methylated IRF-4 promoter (SD-1, IRF-4-positive) to a completely methylated IRF-4 promoter in CML-T1 (IRF-4-negative). |
T8564 |
5361-5555 |
Sentence |
denotes |
Interestingly, the percentage of CpG methylation in the IRF-4 promoter from IRF-4-positive cells was very low (mean 24%) as compared with IRF-4-negative cells (mean 94%) (Figure 4A and Table 1). |
T134 |
5361-5555 |
Sentence |
denotes |
Interestingly, the percentage of CpG methylation in the IRF-4 promoter from IRF-4-positive cells was very low (mean 24%) as compared with IRF-4-negative cells (mean 94%) (Figure 4A and Table 1). |
T8565 |
5556-5922 |
Sentence |
denotes |
A 5′-region (R1) with 13 hypermethylated CpG sites (mean number of methylated clones 5.5 of 8 with 77% methylated CpGs) was found in most cells (except SD-1 and RPMI-8226) and a 3′-region (R3) of 6 hypomethylated CpG sites (mean number of methylated clones 1.7 of 8 with 33% methylated CpGs) was found in most cells (except CML-T1 and U-937) (Figure 4A and Table 1). |
T135 |
5556-5922 |
Sentence |
denotes |
A 5′-region (R1) with 13 hypermethylated CpG sites (mean number of methylated clones 5.5 of 8 with 77% methylated CpGs) was found in most cells (except SD-1 and RPMI-8226) and a 3′-region (R3) of 6 hypomethylated CpG sites (mean number of methylated clones 1.7 of 8 with 33% methylated CpGs) was found in most cells (except CML-T1 and U-937) (Figure 4A and Table 1). |
T8566 |
5923-6200 |
Sentence |
denotes |
Intriguingly, a stretch of 13 CpG sites (#10–22; R2) was detected in between these regions, which were highly methylated in IRF-4-negative (mean number of methylated clones 7.1 of 8 with 89% methylated CpGs) but totally non-methylated in IRF-4-positive cells (Figure 4A and B). |
T136 |
5923-6200 |
Sentence |
denotes |
Intriguingly, a stretch of 13 CpG sites (#10–22; R2) was detected in between these regions, which were highly methylated in IRF-4-negative (mean number of methylated clones 7.1 of 8 with 89% methylated CpGs) but totally non-methylated in IRF-4-positive cells (Figure 4A and B). |
T8567 |
6201-6394 |
Sentence |
denotes |
Furthermore, three CpG sites at the 5′ end (#54, 56, 58) and two CpG motifs at the 3′ end (#1, 2) showed this direct correlation between high methylation status and absence of IRF-4 expression. |
T137 |
6201-6394 |
Sentence |
denotes |
Furthermore, three CpG sites at the 5′ end (#54, 56, 58) and two CpG motifs at the 3′ end (#1, 2) showed this direct correlation between high methylation status and absence of IRF-4 expression. |
T8568 |
6395-6571 |
Sentence |
denotes |
In addition, two CpG sites located in a NFκB (#48) and a SP1 element (#45) are less methylated in IRF-4-positive than in IRF-4-negative cells (mean number of methylated clones: |
T138 |
6395-6571 |
Sentence |
denotes |
In addition, two CpG sites located in a NFκB (#48) and a SP1 element (#45) are less methylated in IRF-4-positive than in IRF-4-negative cells (mean number of methylated clones: |
T8569 |
6572-6588 |
Sentence |
denotes |
1/8 versus 8/8). |
T139 |
6572-6588 |
Sentence |
denotes |
1/8 versus 8/8). |
T8570 |
6589-6703 |
Sentence |
denotes |
These results indicate the involvement of CpG methylation in the regulation of IRF-4 expression in leukemic cells. |
T140 |
6589-6703 |
Sentence |
denotes |
These results indicate the involvement of CpG methylation in the regulation of IRF-4 expression in leukemic cells. |
T9690 |
6705-6788 |
Sentence |
denotes |
In vitro methylation of an IRF-4 promoter-reporter construct decreases its activity |
T141 |
6705-6788 |
Sentence |
denotes |
In vitro methylation of an IRF-4 promoter-reporter construct decreases its activity |
T9691 |
6789-6989 |
Sentence |
denotes |
To provide evidence for a direct effect of methylational status on IRF-4 promoter activity we performed reporter gene assays with IRF-4 promoter constructs before and after their in vitro methylation. |
T142 |
6789-6989 |
Sentence |
denotes |
To provide evidence for a direct effect of methylational status on IRF-4 promoter activity we performed reporter gene assays with IRF-4 promoter constructs before and after their in vitro methylation. |
T9692 |
6990-7121 |
Sentence |
denotes |
A complete methylation of these constructs was checked via restriction assays with methylation-sensitive endonucleases (Figure 5A). |
T143 |
6990-7121 |
Sentence |
denotes |
A complete methylation of these constructs was checked via restriction assays with methylation-sensitive endonucleases (Figure 5A). |
T9693 |
7122-7262 |
Sentence |
denotes |
Intriguingly, methylation of the IRF-4 promoter significantly decreased promoter activity in IRF-4-positive SD-1 cells by 85.0% (Figure 5B). |
T144 |
7122-7262 |
Sentence |
denotes |
Intriguingly, methylation of the IRF-4 promoter significantly decreased promoter activity in IRF-4-positive SD-1 cells by 85.0% (Figure 5B). |
T9694 |
7263-7464 |
Sentence |
denotes |
The silencing effect of CpG methylation was not restricted to IRF-4-positive cells, since in vitro methylation led to a 92.9% abrogation of promoter activity in IRF-4-negative Jurkat cells (Figure 5C). |
T145 |
7263-7464 |
Sentence |
denotes |
The silencing effect of CpG methylation was not restricted to IRF-4-positive cells, since in vitro methylation led to a 92.9% abrogation of promoter activity in IRF-4-negative Jurkat cells (Figure 5C). |
T9695 |
7465-7638 |
Sentence |
denotes |
In contrast, control methylation of a reporter construct with a different promoter (FasL) as well as an empty vector had no effect on the reporter activity (data not shown). |
T146 |
7465-7638 |
Sentence |
denotes |
In contrast, control methylation of a reporter construct with a different promoter (FasL) as well as an empty vector had no effect on the reporter activity (data not shown). |
T9696 |
7639-7733 |
Sentence |
denotes |
These data proved a direct association between methylation and activity of the IRF-4 promoter. |
T147 |
7639-7733 |
Sentence |
denotes |
These data proved a direct association between methylation and activity of the IRF-4 promoter. |
T10244 |
7735-7862 |
Sentence |
denotes |
mRNA expression of DNA methyltransferases and methyl-CpG-binding proteins may not be associated with IRF-4 promoter methylation |
T148 |
7735-7862 |
Sentence |
denotes |
mRNA expression of DNA methyltransferases and methyl-CpG-binding proteins may not be associated with IRF-4 promoter methylation |
T10245 |
7863-8089 |
Sentence |
denotes |
Since abundance of DNMT and MBP contribute to promoter regulation via methylation (25,26,28), we studied their mRNA expression to investigate a possible mechanism for the observed methylation differences in the IRF-4 promoter. |
T149 |
7863-8089 |
Sentence |
denotes |
Since abundance of DNMT and MBP contribute to promoter regulation via methylation (25,26,28), we studied their mRNA expression to investigate a possible mechanism for the observed methylation differences in the IRF-4 promoter. |
T10246 |
8090-8287 |
Sentence |
denotes |
To this end, we did not detect a significant difference in DNMT (DNMT1, DNMT3A and DNMT3B) or MBP (MBD1, MBD2, MBD4 and MeCP) mRNA expression between IRF-4-positive and -negative cells (Figure 5D). |
T150 |
8090-8287 |
Sentence |
denotes |
To this end, we did not detect a significant difference in DNMT (DNMT1, DNMT3A and DNMT3B) or MBP (MBD1, MBD2, MBD4 and MeCP) mRNA expression between IRF-4-positive and -negative cells (Figure 5D). |
T10247 |
8288-8443 |
Sentence |
denotes |
In fact, all analyzed cells had moderate to high mRNA levels of these tested DNMT/MBPs and differences in expression were not correlated with IRF-4 status. |
T151 |
8288-8443 |
Sentence |
denotes |
In fact, all analyzed cells had moderate to high mRNA levels of these tested DNMT/MBPs and differences in expression were not correlated with IRF-4 status. |
T10248 |
8444-8612 |
Sentence |
denotes |
These results indicate a distinct cause of the methylation differences in IRF-4-positive and -negative cells rather than changes in the DNMT and MBP mRNA transcription. |
T152 |
8444-8612 |
Sentence |
denotes |
These results indicate a distinct cause of the methylation differences in IRF-4-positive and -negative cells rather than changes in the DNMT and MBP mRNA transcription. |